PMID- 38401691 OWN - NLM STAT- MEDLINE DCOM- 20240427 LR - 20240427 IS - 1873-4847 (Electronic) IS - 0955-2863 (Linking) VI - 128 DP - 2024 Jun TI - Nutrient composition of different energy-restricted diets determines plasma endocannabinoid profiles and adipose tissue DAGL-alpha expression; a 12-week randomized controlled trial in subjects with abdominal obesity. PG - 109605 LID - S0955-2863(24)00038-X [pii] LID - 10.1016/j.jnutbio.2024.109605 [doi] AB - The endocannabinoid system (ECS) is dysregulated during obesity and metabolic disorders. Weight loss favours the re-establishment of ECS homeostatic conditions, but also the fatty acid composition of the diet can modulate endocannabinoid profiles. However, the combined impact of nutrient quality and energy restriction on the ECS remains unclear. In this 12 weeks randomized controlled trial, men and women (40-70 years) with obesity (BMI: 31.3 +/- 3.5 kg/ m(2)) followed either a low nutrient quality 25% energy-restricted (ER) diet (n=39) high in saturated fats and fructose, or a high nutrient quality ER diet (n=34) amongst others enriched in n-3 polyunsaturated fatty acids (PUFAs) or kept their habitual diet (controls). Profiles of plasma- and adipose N-acylethanolamines and mono-acyl glycerol esters were quantified using LC-MS/MS. Gene expression of ECS-related enzymes and receptors was determined in adipose tissue. Measurements were performed under fasting conditions before and after 12 weeks. Our results showed that plasma level of the DHA-derived compound docosahexaenoylethanolamide (DHEA) was decreased in the low nutrient quality ER diet (P<0.001) compared with the high nutrient quality ER diet, whereas anandamide (AEA) and arachidonoylglycerol (2-AG) levels were unaltered. However, adipose tissue gene expression of the 2-AG synthesizing enzyme diacylglycerol lipase alpha (DAGL-alpha) was increased following the low nutrient quality ER diet (P<.009) and differed upon intervention with both other diets. Concluding, nutrient quality of the diet affects N-acylethanolamine profiles and gene expression of ECS-related enzymes and receptors even under conditions of high energy restriction in abdominally obese humans. ClinicalTrials.gov NCT02194504. CI - Copyright (c) 2024 The Author(s). Published by Elsevier Inc. All rights reserved. FAU - Wang, Ya AU - Wang Y AD - Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands; The Laboratory of Food Chemistry, Wageningen University, Wageningen, The Netherlands. FAU - Balvers, Michiel G J AU - Balvers MGJ AD - Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands. FAU - Esser, Diederik AU - Esser D AD - Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands. FAU - Schutte, Sophie AU - Schutte S AD - Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands. FAU - Vincken, Jean-Paul AU - Vincken JP AD - The Laboratory of Food Chemistry, Wageningen University, Wageningen, The Netherlands. FAU - Afman, Lydia A AU - Afman LA AD - Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands. FAU - Witkamp, Renger F AU - Witkamp RF AD - Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands. FAU - Meijerink, Jocelijn AU - Meijerink J AD - Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands. Electronic address: jocelijn.meijerink@wur.nl. LA - eng SI - ClinicalTrials.gov/NCT02194504 PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20240223 PL - United States TA - J Nutr Biochem JT - The Journal of nutritional biochemistry JID - 9010081 RN - 0 (Endocannabinoids) RN - EC 3.1.1.34 (Lipoprotein Lipase) RN - 0 (N-acylethanolamines) RN - 0 (Ethanolamines) SB - IM MH - Humans MH - *Endocannabinoids/metabolism/blood MH - Middle Aged MH - Male MH - Female MH - Adult MH - Aged MH - *Caloric Restriction MH - *Adipose Tissue/metabolism MH - *Obesity, Abdominal/diet therapy/metabolism/blood MH - *Lipoprotein Lipase/metabolism MH - Ethanolamines/metabolism MH - Nutrients/metabolism OTO - NOTNLM OT - CB(1) OT - Docosahexaenoylethanolamide (DHEA) OT - Endocannabinoid system OT - Metabolic disorders OT - N-acylethanolamines OT - n-3 PUFA COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2024/02/25 00:42 MHDA- 2024/04/28 07:24 CRDT- 2024/02/24 19:14 PHST- 2023/10/19 00:00 [received] PHST- 2024/02/14 00:00 [revised] PHST- 2024/02/19 00:00 [accepted] PHST- 2024/04/28 07:24 [medline] PHST- 2024/02/25 00:42 [pubmed] PHST- 2024/02/24 19:14 [entrez] AID - S0955-2863(24)00038-X [pii] AID - 10.1016/j.jnutbio.2024.109605 [doi] PST - ppublish SO - J Nutr Biochem. 2024 Jun;128:109605. doi: 10.1016/j.jnutbio.2024.109605. Epub 2024 Feb 23.